MetaCap

IGC Pharma Statistics

NYSE: IGCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.168-0.016 (-8.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IGC Pharma by the numbers

IGC Pharma has a market capitalization of $19.6 million based on 116.69M shares outstanding. With trailing EPS of $-0.07, IGC Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 38.5% below its 200-day average.

Average daily trading volume is 615.25K shares, or about $103,361 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IGC valuation vs. peer median

IGC compared with the median of 8 peer companies
MetricIGCPeer medianDifference
Market cap$19.60M$19.33M+1%
Avg. volume615.25K457.29K+35%

Peer median across 8 companies: TXMD, ACET, RNAZ, AARD, CPHI, COCP, MRKR, KTTA.

Valuation

Market cap
$19.60M
Price / sales (latest FY)
15.42
EPS (TTM)
$-0.07

Price and trading

Previous close
0.184
Open
0.1832
Day range
0.168 – 0.1863
52-week range
0.08 – 0.36
52-week change
-47.50%
Beta
—
Volume
500.33K

Dividends and events

Additional statistics

Market Cap
19.60M
Forward Pe
-2.10
Eps
-0.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
0.36
Week52 Low
0.08
Avg Volume
615.25K
Shares Outstanding
116.69M
Ma50
0.24
Ma200
0.27
Pct From52w High
-53.33%
Pct From52w Low
110.00%

Related